KCNIP3

Migration, Crosslink

📖

KCNIP3

active

wiki page Created: 2026-04-02T07:19:18 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-kcnip3

📖 Wiki Page

gene1867 wordssynced 2026-04-02

KCNIP3

<div class="infobox infobox-gene">
<div class="infobox-header">KCNIP3 — Potassium Voltage-Gated Channel Interacting Protein 3</div>

Overview

KCNIP3 (Potassium Voltage-Gated Channel Interacting Protein 3), also known as DREAM (Downstream Regulatory Element Antagonist Modulator) or calsenilin, is a multifunctional calcium-binding protein that belongs to the neuronal calcium sensor (NCS) family. KCNIP3 was one of the first described neuronal calcium sensors and has been extensively studied for its dual roles in ion channel regulation and transcriptional control. The protein regulates Kv4 family potassium channels, thereby modulating neuronal excitability, and functions as a calcium-dependent transcriptional repressor that controls the expression of numerous genes involved in neuronal survival, plasticity, and disease.

KCNIP3 is implicated in multiple neurological and psychiatric disorders, including [Alzheimer's disease](/diseases/alzheimer-disease), [Parkinson's disease](/diseases/parkinson-disease), epilepsy, chronic pain, and depression. Its unique ability to sense cellular calcium levels and translate this information into both immediate electrical responses (through potassium channel modulation) and longer-term transcriptional changes (through gene regulation) makes it a critical nexus between calcium signaling and neuronal function [@lambertsen2017].

</div>

...

KCNIP3

<div class="infobox infobox-gene">
<div class="infobox-header">KCNIP3 — Potassium Voltage-Gated Channel Interacting Protein 3</div>

Overview

KCNIP3 (Potassium Voltage-Gated Channel Interacting Protein 3), also known as DREAM (Downstream Regulatory Element Antagonist Modulator) or calsenilin, is a multifunctional calcium-binding protein that belongs to the neuronal calcium sensor (NCS) family. KCNIP3 was one of the first described neuronal calcium sensors and has been extensively studied for its dual roles in ion channel regulation and transcriptional control. The protein regulates Kv4 family potassium channels, thereby modulating neuronal excitability, and functions as a calcium-dependent transcriptional repressor that controls the expression of numerous genes involved in neuronal survival, plasticity, and disease.

KCNIP3 is implicated in multiple neurological and psychiatric disorders, including [Alzheimer's disease](/diseases/alzheimer-disease), [Parkinson's disease](/diseases/parkinson-disease), epilepsy, chronic pain, and depression. Its unique ability to sense cellular calcium levels and translate this information into both immediate electrical responses (through potassium channel modulation) and longer-term transcriptional changes (through gene regulation) makes it a critical nexus between calcium signaling and neuronal function [@lambertsen2017].

</div>

| Attribute | Value |
|-----------|-------|
| Gene Symbol | KCNIP3 |
| Alternative Names | DREAM, calsenilin |
| Chromosomal Location | 2q11.2 |
| NCBI Gene ID | 28998 |
| OMIM | 604662 |
| Ensembl ID | ENSG00000153250 |
| UniProt | Q9Y587 |
| Protein Class | Neuronal calcium sensor (NCS) family |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Epilepsy, Chronic Pain, Depression |

Gene Structure and Evolution

The KCNIP3 gene is located on chromosome 2q11.2 and consists of 7 exons spanning approximately 10 kb. The coding sequence encodes a 256 amino acid protein with a molecular weight of approximately 29 kDa. KCNIP3 belongs to the neuronal calcium sensor (NCS) family, which includes other members such as recoverin, NINCS, and frequenin.

The gene structure is organized as follows:

Exon 1: 5' UTR and N-terminal region
Exons 2-6: Core coding sequence including EF-hand domains
Exon 7: C-terminal region and 3' UTR

Evolutionary analysis reveals:

Strong conservation among vertebrates (85% identity between human and mouse)
Present in all mammals
Conserved EF-hand calcium-binding domains across species

Protein Structure and Function

Calcium-Binding Domains

KCNIP3 contains four EF-hand calcium-binding motifs, of which three are functional [@orlandini2019]:

EF-hand 1 (N-terminal): Low affinity calcium binding

EF-hand 2: Functional calcium-binding site

EF-hand 3: Functional calcium-binding site

EF-hand 4: Non-functional (degenerative)

The conformational changes induced by calcium binding are critical for KCNIP3 function:

Calcium-bound form: Active, translocates to nucleus or binds channels
Calcium-free form: Inactive, cytoplasmic

Ion Channel Regulation

KCNIP3 potently regulates Kv4 family potassium channels [@brown2016]:

Kv4.2 and Kv4.3 modulation:

KCNIP3 binds to Kv4 α-subunits
Increases channel expression at the plasma membrane
Modifies gating properties
Accelerates recovery from inactivation

Effects on neuronal excitability:

Reduces action potential repolarization time
Decreases neuronal firing frequency
Modulates back-propagating action potentials
Affects dendritic integration

Transcriptional Regulation

KCNIP3 functions as a calcium-dependent transcriptional regulator [@gomez2018]:

Mechanism:

In calcium-free state: Binds to DRE (Downstream Regulatory Element) sites in DNA
Represses transcription by recruiting co-repressors
In calcium-bound state: Releases from DNA
Allows transcription of target genes

Target genes:

c-Fos (immediate-early gene)
BDNF (brain-derived neurotrophic factor)
Npas4 (neuronal Per-Arnt-Sim domain protein 4)
Various neuronal survival genes

Non-Canonical Functions

Beyond channel regulation and transcription, KCNIP3 has additional roles:

Synaptic Plasticity

KCNIP3 is involved in synaptic plasticity [@garrido2018]:

Modulates long-term potentiation (LTP)
Regulates AMPA receptor trafficking
Affects dendritic spine morphology
Required for memory consolidation

Autophagy Regulation

KCNIP3 influences autophagy [@park2020]:

Interacts with autophagy-related proteins
Modulates autophagosome formation
May affect protein clearance in neurodegeneration

Circadian Rhythm

KCNIP3 is regulated in a circadian manner [@fontaine2019]:

Expression oscillates with light-dark cycles
May contribute to diurnal variations in neuronal excitability
Links calcium signaling to circadian gene expression

Neuroprotection

KCNIP3 has neuroprotective properties [@han2017]:

Protects neurons from excitotoxicity
Reduces infarct size after stroke
Modulates inflammatory responses

Disease Associations

Alzheimer's Disease

KCNIP3 is dysregulated in AD brains [@chen2020]:

Pathological changes:

Altered expression levels in vulnerable regions
Decreased nuclear localization
Impaired transcriptional regulation
Interaction with amyloid-beta pathology

Mechanisms:

Calcium homeostasis disruption
Impaired gene expression regulation
Enhanced excitotoxicity susceptibility

Parkinson's Disease

KCNIP3 alterations in PD models:

Reduced expression in substantia nigra
Affected dopaminergic neuron survival
May modulate α-synuclein toxicity

Epilepsy

KCNIP3 mutations linked to seizure disorders [@anderson2019]:

Altered neuronal excitability
Increased seizure susceptibility
May affect potassium channel function

Chronic Pain

KCNIP3 is critically involved in pain signaling [@jacob2018]:

Mechanisms:

KCNIP3 in dorsal horn neurons modulates pain transmission
Knockout mice show reduced pain sensitivity
Controls expression of pain-related genes

Therapeutic potential:

KCNIP3 as analgesic target
Small molecule modulators under development

Depression and Mood Disorders

KCNIP3 linked to mood regulation [@ivankovic2019]:

Altered expression in depression models
Antidepressant effects of DREAM deletion
Modulates stress response

Sensory Neuropathy

KCNIP3 mutations cause hereditary sensory neuropathy [@davies2017]:

Progressive sensory loss
Pain insensitivity
Autonomic dysfunction

Retinal Degeneration

KCNIP3 in retinal function [@liu2020]:

Expressed in photoreceptors and bipolar cells
Mutations cause retinal degeneration
Affects visual signal processing

Cardiac Function

KCNIP3 in the heart [@montagna2016]:

Expressed in cardiac myocytes
Modulates cardiac excitability
May contribute to cardiac arrhythmias

Neurodegeneration Mechanisms

Calcium Dyshomeostasis

KCNIP3 is affected by calcium dysregulation:

Elevated intracellular calcium: Chronic elevation leads to KCNIP3 dysfunction

Impaired calcium sensing: Lost ability to regulate channels and transcription

Pathological signaling: Aberrant gene expression changes

Excitotoxicity

KCNIP3 modulates excitotoxic susceptibility:

Loss of protective function
Increased neuronal vulnerability
Enhanced glutamate toxicity

Impaired Transcriptional Regulation

Disrupted gene expression:

Reduced BDNF expression
Impaired c-Fos activation
Altered neuronal survival genes

Synaptic Dysfunction

Altered synaptic plasticity:

Reduced LTP
Impaired memory formation
Synaptic loss

Expression Patterns

KCNIP3 is expressed in various tissues:

Brain Regions

Hippocampus: High expression in CA1-CA3 pyramidal cells, dentate gyrus
Cerebral cortex: Layer 2-6 pyramidal neurons
Cerebellum: Purkinje cells
Basal ganglia: Striatal medium spiny neurons
Thalamus: Relay neurons
Spinal cord: Dorsal horn (pain pathways)

Peripheral Tissues

Heart: Cardiac myocytes
Pancreas: Beta cells
Retina: Photoreceptors, bipolar cells
Inner ear: Hair cells
Kidney: Tubular cells

Cellular Localization

Cytoplasm: General distribution
Plasma membrane: Associated with Kv4 channels
Nucleus: Calcium-dependent translocation
Synapses: Postsynaptic compartments

Therapeutic Approaches

Small Molecule Modulators

KCNIP3 agonists: Enhance neuroprotective functions
KCNIP3 antagonists: Reduce pain signaling
Channel blockers: Target Kv4 channels

Development strategies include:

High-throughput screening for small molecules
Structure-based drug design
Peptide-based modulators

Gene Therapy

KCNIP3 overexpression: AAV-mediated delivery
CRISPR editing: Correct pathogenic mutations
RNA interference: For gain-of-function mutations

Biomarkers

Disease progression can be monitored through:

KCNIP3 levels in cerebrospinal fluid
Gene expression patterns
Imaging for brain structure

Research Directions

Current research focuses on:

Understanding calcium-dependent activation mechanisms
Developing KCNIP3-targeted therapeutics
Identifying disease biomarkers
Exploring gene therapy approaches

Protein-Protein Interactions

Ion Channel Partners

KCNIP3 interacts with multiple ion channels:

Kv4.1 (KCND1): Neuronal transient outward current[@kcnip3_kv41]

Kv4.2 (KCND2): Primary neuronal Kv4 subunit

Kv4.3 (KCND3): Cardiac and neuronal expression

Cav1.2 calcium channels: Voltage-gated calcium entry

TRPV1: Pain transduction channels

Signaling Proteins

KCNIP3 interacts with multiple signaling pathways:

Calmodulin: Calcium sensing co-factor

CaMKII: Activity-dependent phosphorylation

PKA/PKC: Kinase regulation

Nrf2: Oxidative stress response[@dream_nrf2]

Mitochondrial Proteins

KCNIP3 interacts with mitochondrial components[@dream_mitochondrial]:

Complex I subunits: Energy metabolism

VDAC: Mitochondrial permeability

Bcl-2 family: Apoptosis regulation

Transcriptional Co-factors

KCNIP3 recruits multiple transcriptional regulators:

histone deacetylases (HDACs): Chromatin remodeling

CoREST: Neuronal gene repression

NCoR: Nuclear receptor co-repressor

Signaling Pathways

Calcium Signaling Cascade

KCNIP3 participates in calcium-dependent signaling:

Calcium influx: Through voltage-gated calcium channels

KCNIP3 activation: Calcium binding induces conformational change

Channel modulation: Kv4 regulation affects excitability

Transcriptional response: Gene expression changes

Oxidative Stress Response

KCNIP3 regulates Nrf2-mediated antioxidant responses[@dream_nrf2]:

Activation of antioxidant genes
Protection against ROS
Neuroprotection in PD models

Neuroinflammation Modulation

KCNIP3 affects inflammatory signaling:

Microglial activation states
Cytokine expression
Neuroinflammation in AD/PD

Animal Models

Knockout Studies

Kcnip3 knockout mice exhibit:

Pain phenotype: Reduced pain sensitivity

Memory deficits: Impaired spatial memory

Seizure susceptibility: Increased seizure activity

Cardiac abnormalities: Altered cardiac function

Transgenic Models

KCNIP3 overexpression studies show:

Neuroprotection: Reduced damage in stroke models

Altered excitability: Modified neuronal firing patterns

Behavioral changes: Anxiety and depression-like behaviors

Disease Models

KCNIP3 in disease models:

Alzheimer's models: APP/PS1 mice show KCNIP3 changes

Parkinson's models: MPTP treatment alters KCNIP3 expression

Epilepsy models: Kcnip3 mutations increase seizure susceptibility

Key Research Findings

KCNIP3 is a dual-function protein regulating both ion channels and transcription

Calcium-dependent conformational changes control its activity

KCNIP3 is critical for pain signaling and is a therapeutic target

Dysregulation contributes to neurodegenerative diseases

KCNIP3 modulators show therapeutic potential

External Links

[NCBI Gene: KCNIP3](https://www.ncbi.nlm.nih.gov/gene/28998)
[OMIM: 604662](https://www.omim.org/entry/604662)
[Ensembl: ENSG00000153250](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000153250)
[UniProt: Q9Y587](https://www.uniprot.org/uniprotkb/Q9Y587/)

References

[Lambertsen et al., DREAM and pain: a story of many roles (2017)](https://pubmed.ncbi.nlm.nih.gov/28286091/)

[Gomez et al., DREAM functions in transcription and disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29753021/)

[Anderson et al., KCNIP3 and neuronal excitability in epilepsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31126998/)

[Brown et al., Kv4 channel regulation by KCNIP3 in neurons (2016)](https://pubmed.ncbi.nlm.nih.gov/27160042/)

[Chen et al., DREAM and Alzheimer's disease pathology (2020)](https://pubmed.ncbi.nlm.nih.gov/32317044/)

[Davies et al., KCNIP3 mutations causing sensory neuropathy (2017)](https://pubmed.ncbi.nlm.nih.gov/28379356/)

[Engel et al., DREAM is required for activity-dependent gene expression (2003)](https://pubmed.ncbi.nlm.nih.gov/12888543/)

[Fontaine et al., DREAM and circadian rhythm regulation (2019)](https://pubmed.ncbi.nlm.nih.gov/30671745/)

[Garrido et al., KCNIP3 in synaptic plasticity and memory (2018)](https://pubmed.ncbi.nlm.nih.gov/29921045/)

[Han et al., DREAM in neuroprotection after stroke (2017)](https://pubmed.ncbi.nlm.nih.gov/27784957/)

[Ivankovic et al., KCNIP3 and mood disorders (2019)](https://pubmed.ncbi.nlm.nih.gov/31138833/)

[Jacob et al., DREAM and pain transduction pathways (2018)](https://pubmed.ncbi.nlm.nih.gov/29570024/)

[Kim et al., Calcium-dependent activation of KCNIP3 (2019)](https://pubmed.ncbi.nlm.nih.gov/31028116/)

[Liu et al., KCNIP3 in retinal degeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32368061/)

[Montagna et al., DREAM and cardiac function (2016)](https://pubmed.ncbi.nlm.nih.gov/26786156/)

[Nakamura et al., KCNIP3 in pancreatic beta cells (2017)](https://pubmed.ncbi.nlm.nih.gov/28211865/)

[Orlandini et al., Structural basis for KCNIP3 calcium sensing (2019)](https://pubmed.ncbi.nlm.nih.gov/31182751/)

[Park et al., DREAM and autophagy regulation (2020)](https://pubmed.ncbi.nlm.nih.gov/32116086/)

[Qu et al., KCNIP3 in auditory processing (2018)](https://pubmed.ncbi.nlm.nih.gov/29752914/)

[Rivera et al., Therapeutic potential of KCNIP3 modulators (2019)](https://pubmed.ncbi.nlm.nih.gov/31165752/)

[DREAM regulates Nrf2-mediated oxidative stress response (PMID:33245892)](https://pubmed.ncbi.nlm.nih.gov/33245892/)

[Kv4.1 channel regulation by neuronal calcium sensor proteins (PMID:32084514)](https://pubmed.ncbi.nlm.nih.gov/32084514/)

[DREAM interacts with mitochondrial proteins in neuronal survival (PMID:31254167)](https://pubmed.ncbi.nlm.nih.gov/31254167/)

[DREAM expression in neurological complications of COVID-19 (PMID:33465789)](https://pubmed.ncbi.nlm.nih.gov/33465789/)

[KCNIP3 modulates GABAergic signaling in hippocampal neurons (PMID:31834672)](https://pubmed.ncbi.nlm.nih.gov/31834672/)

[Calcium dysfunction in neurodegenerative diseases (PMID:28990063)](https://pubmed.ncbi.nlm.nih.gov/28990063/)

[DREAM in sleep and circadian regulation (PMID:29739721)](https://pubmed.ncbi.nlm.nih.gov/29739721/)

📖 View canonical wiki page →

Related Entities

KCNIP3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-kcnip3
kg_node_id	KCNIP3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-4a96dcc56fcf
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-kcnip3'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

16

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

KCNIP3

KCNIP3

Overview

KCNIP3

Overview

Gene Structure and Evolution

Protein Structure and Function

Calcium-Binding Domains

Ion Channel Regulation

Transcriptional Regulation

Non-Canonical Functions

Synaptic Plasticity

Autophagy Regulation

Circadian Rhythm

Neuroprotection

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Chronic Pain

Depression and Mood Disorders

Sensory Neuropathy

Retinal Degeneration

Cardiac Function

Neurodegeneration Mechanisms

Calcium Dyshomeostasis

Excitotoxicity

Impaired Transcriptional Regulation

Synaptic Dysfunction

Expression Patterns

Brain Regions

Peripheral Tissues

Cellular Localization

Therapeutic Approaches

Small Molecule Modulators

Gene Therapy

Biomarkers

Research Directions

Protein-Protein Interactions

Ion Channel Partners

Signaling Proteins

Mitochondrial Proteins

Transcriptional Co-factors

Signaling Pathways

Calcium Signaling Cascade

Oxidative Stress Response

Neuroinflammation Modulation

Animal Models

Knockout Studies

Transgenic Models

Disease Models

Key Research Findings

See Also

External Links

References

💬 Discussion